Passage Bio, Inc.
PASG • NASDAQ • Stock Fundamentals
Passage Bio, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO William Chou, with a market cap of $17.8M.
Market Cap$17.8M
Employees85.0
CEOWilliam Chou
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
PAS
Passage Bio, Inc. FAQ
Common questions about Passage Bio, Inc.
Passage Bio, Inc. (PASG) has a market capitalization of $17.8M and trades on NASDAQ.
Passage Bio, Inc. has approximately 85 employees.